Trial Profile
Effects of metabolic syndrome on efficacy of abiraterone in patients with prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Abiraterone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 Nov 2015 New trial record